Home Newsfeeds Credit Suisse Maintains Outperform on Acuity Brands, Lowers Price Target to $200

Credit Suisse Maintains Outperform on Acuity Brands, Lowers Price Target to $200

Credit Suisse analyst John Walsh maintains Acuity Brands (NYSE:AYI) with a Outperform and lowers the price target from $211 to $200.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Credit Suisse analyst John Walsh maintains Acuity Brands (NYSE:AYI) with a Outperform and lowers the price target from $211 to $200.

Needham Maintains Buy on Datadog, Raises Price Target to $105

By Benzinga Newsdesk

February 17, 5:38 AM

Needham analyst Mike Cikos maintains Datadog (NASDAQ:DDOG) with a Buy and raises the price target from $90 to $105.

DDOG

ASP Isotopes Receives Purchase Order From A Leading Global Industrial Gases Company, Covering The Supply Of highly Enriched Silicon-28, Which Is Expected To Be Supplied In 2024; Financial Terms Not Disclosed

By Benzinga Newsdesk

June 3, 8:46 AM

- Purchase order covers supply of highly enriched silicon-28, which is expected to be supplied in 2024.- This purchase order is the second order for the supply of enriched electronic gases in 2024.- The Company is in

ASPI

Medifast Q3 Adj. EPS $3.32 Beats $1.91 Estimate, Sales $390.40M Beat $349.30M Estimate

By Benzinga Newsdesk

November 3, 5:14 PM

Medifast (NYSE:MED) reported quarterly earnings of $3.32 per share which beat the analyst consensus estimate of $1.91 by 73.82 percent. This is a 6.74 percent decrease over earnings of $3.56 per share from the same

MED

Analyst Ratings

Where Prosperity Bancshares Stands With Analysts

By Benzinga Insights

April 27, 1:01 PM

Within the last quarter, Prosperity Bancshares (NYSE:PB) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

Credit Suisse Maintains Outperform on Acuity Brands, Lowers Price Target to $200

Related Posts

Needham Maintains Buy on Datadog, Raises Price Target to $105

ASP Isotopes Receives Purchase Order From A Leading Global Industrial Gases Company, Covering The Supply Of highly Enriched Silicon-28, Which Is Expected To Be Supplied In 2024; Financial Terms Not Disclosed

Medifast Q3 Adj. EPS $3.32 Beats $1.91 Estimate, Sales $390.40M Beat $349.30M Estimate

Where Prosperity Bancshares Stands With Analysts